XML 13 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Interim Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Sep. 30, 2022
Current    
Cash and cash equivalents $ 153,466,962 $ 149,157,861
Incentive and tax receivables 4,737,661 3,192,580
Prepaid expenses and other current assets 981,774 354,162
Total Assets 159,186,397 152,704,603
Current Liabilities    
Accounts payable 6,281,742 3,824,777
Accrued liabilities - Note 4 6,822,838 5,944,953
Deferred grant income - Note 3 916,763 443,831
Total Liabilities 14,021,343 10,213,561
Commitments and Contingencies - Note 6
Capital stock Authorized:10,000,000 preferred stock, par value $0.001 per share
Capital stock Authorized:200,000,000 common stock, par value $0.001 per share 80,235,398 common shares (September 30, 2022 - 77,942,815) 80,236 77,944
Additional paid-in capital 416,727,598 387,976,881
Accumulated deficit (271,642,780) (245,563,783)
Total Stockholders' Equity 145,165,054 142,491,042
Total Liabilities and Stockholders' Equity $ 159,186,397 $ 152,704,603